Resveratrol supplementation worsen the dysregulation of genes involved in hepatic lipid homeostasis observed in hyperhomocysteinemic mice

Food and Chemical Toxicology

Volumn 47, Issue 1, 2009, Pages 230-236

  Noll, Christophe ^a   Hamelet, Julien ^a   Ducros, Véronique ^b   Belin, Nicole ^b   Paul, Jean Louis ^c,d   Delabar, Jean Maurice ^a   Janel, Nathalie ^a,e  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e INSERM   (France)

Author keywords

Cystathionine beta synthase; Homocysteine; Lecithin:cholesterol acyltransferase; Mice; Paraoxonase 1; Resveratrol

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CATECHIN; CHOLESTEROL ACYLTRANSFERASE; CYSTATHIONINE BETA SYNTHASE; DRINKING WATER; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LIPID; METHIONINE; PHOSPHATIDYLCHOLINE; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE DISRUPTION; HETEROZYGOSITY; HOMEOSTASIS; HYPERHOMOCYSTEINEMIA; LIPID LIVER LEVEL; MALE; MOUSE; NONHUMAN; RED WINE;

ANIMALS; APOLIPOPROTEIN A-I; CYSTATHIONINE BETA-SYNTHASE; DIETARY SUPPLEMENTS; GENE EXPRESSION REGULATION; GENOTYPE; HYPERHOMOCYSTEINEMIA; LIPID METABOLISM; LIVER; MICE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE; SCAVENGER RECEPTORS, CLASS B; STILBENES;

MURINAE; MUS;

EID: 58149279278     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.11.005     Document Type: Article

References (40)

1. Alberto J.M., Hamelet J., Noll C., Blaise S., Bronowicki J.P., Guéant J.L., Delabar J.M., and Janel N. Mice deficient in cystathionine beta synthase display altered homocysteine remethylation pathway. Mol. Genet. Metab. 91 (2007) 396-398
2. Aviram M., and Fuhrman B. Wine flavonoids protect against LDL oxidation and atherosclerosis. Ann. N. Y. Acad. Sci. 957 (2002) 146-161
3. Casper R.F., Quesne M., Rogers I.M., Shirota T., Jolivet A., Milgrom E., and Savouret J.F. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol. Pharmacol. 56 (1999) 784-790
4. Dayal S., Bottiglieri T., Arning E., Maeda N., Malinow M.R., Sigmund C.D., Heistad D.D., Faraci F.M., and Lentz S.R. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ. Res. 88 (2001) 1203-1209
5. Durrington P.N., Mackness B., and Mackness M.I. Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 473-480
6. Finkelstein J.D. The metabolism of homocysteine: pathways and regulation. Eur. J. Pediatr. 157 (1998) S40-S44
7. Finkelstein J.D. Pathways and regulation of homocysteine metabolism in mammals. Semin. Thromb. Hemost. 26 (2000) 219-225
8. Finkelstein J.D., Haris B.J., Martin J.J., and Kyle W.E. Regulation of hepatic betaine-homocysteine methyltransferase by dietary methionine. Biochem. Biophys. Res. Commun. 108 (1982) 344-348
9. Forte T.M., Oda M.N., Knoff L., Frei B., Suh J., Harmony J.A., Stuart W.D., Rubin E.M., and Ng D.S. Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration. J. Lipid Res. 40 (1999) 1276-1283
10. Fortin L.J., and Genest J. Measurement of homocyst(e)ine in the prediction of atherosclerosis. Clin. Biochem. 28 (1995) 155-162
11. Frankel E.N., Kanner J., German J.B., Parks E., and Kinsella J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341 (1993) 454-457
12. Gao X., Debb D., Media J., Divine G., Jiang H., Chapman R.A., and Gautam S.C. Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects. Biochem. Pharmacol. 66 (2003) 2427-2435
13. Garcia-Trevijano E.R., Latasa M.U., Carretero M.V., Berasain C., Mato J.M., and Avila M.A. S-Adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver. FASEB J. 14 (2000) 2511-2518
14. Gellekink H., van Oppenraaij-Emmerzaal D., van Rooij A., Struys E.A., den Heijer M., and Blom H.J. Stable-isotope dilution liquid chromatography-electrospray injection tandem mass spectrometry method for fast, selective measurement of S-adenosylmethionine and S-adenosylhomocysteine in plasma. Clin. Chem. 51 (2005) 1487-1492
15. Gouedard C., Barouki R., and Morel Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cell. Biol. 24 (2004) 5209-5222
16. Gouedard C., Barouki R., and Morel Y. Induction of the Paraoxonase-1 gene expression by reveratrol. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2378-2383
17. Hamelet J., Demuth K., Paul J.L., Delabar J.M., and Janel N. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice. J. Hepatol. 46 (2007) 151-159
18. Hamelet J., Demuth K., Dairou J., Ledru A., Paul J.L., Dupret J.M., Delabar J.M., Rodrigues-Lima F., and Janel N. Effects of catechin on homocysteine metabolism in hyperhomocysteinemic mice. Biochem. Biophys. Res. Commun. 255 (2007) 221-227
19. Hamelet J., Aït-Yahya-Graison E., Matulewicz E., Noll C., Badel-Chagnon A., Camproux A.C., Demuth K., Paul J.L., Delabar J.M., and Janel N. Homocysteine threshold value based on cystathionine beta synthase and paraoxonase 1 activities in mice. Eur. J. Clin. Invest. 37 (2007) 933-938
20. Heo Y.H., Kim S., Park J.E., Jeong L.S., and Lee S.K. Induction of quinone reductase activity by stilbene analogs in mouse Hepa 1c1c7 cells. Arch. Pharm. Res. 24 (2001) 597-600
21. Hsieh T.C., Lu X., Wang Z., and Wu J.M. Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2. Med. Chem. 2 (2006) 275-285
22. Jakubowski H. Calcium-dependent human serum homocysteine thiolactone hydrolase, A protective mechanism against protein N-homocysteinylation. J. Biol. Chem. 275 (2000) 3957-3962
23. James R.W., and Deakin S.P. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Radic. Biol. Med. 37 (2004) 1986-1994
24. Janel N., Robert K., Chabert C., Ledru A., Gouedard C., Barouki R., Delabar J.M., and Chasse J.F. Mouse liver paraoxonase-1 gene expression is downregulated in hyperhomocysteinemia. Thromb. Haemost. 92 (2004) 221-222
25. Likogianni V., Janel N., Ledru A., Beaune P., Paul J.L., and Demuth K. Thiol compounds metabolism in mice, rats and humans: comparative study and potential explanation of rodents protection against vascular diseases. Clin. Chim. Acta 372 (2006) 140-146
26. Mikael L.G., Genest J., and Rozen R. Elevated homocysteine reduces apolipoprotein A-1 expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ. Res. 98 (2006) 564-571
27. Miller J.W., Nadeau M.R., Smith D., and Selhub J. Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism. Biochem. J. 298 (1994) 415-419
28. Namekata K., Enokido Y., Ishii I., Nagai Y., Harada T., and Kimura H. Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. J. Biol. Chem. 279 (2004) 52961-52969
29. Noll C., Hamelet J., Matulewicz E., Paul J.L., Delabar J.M., Janel N., 2009. Effects of red wine polyphenolic compounds on paraoxonase 1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice, J. Nutr. Biochem., in press.
30. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
31. Rivera S.P., Saarikoski S.T., Sun W., and Hankinson O. Identification of novel dioxin-responsive genes by representational difference analysis. Xenobiotica 37 (2007) 271-279
32. Robert K., Chassé J.F., Santiard-Baron D., Vayssettes C., Chabli A., Aupetit J., Maeda N., Kamoun P., London J., and Janel N. Altered gene expression in liver from a murine model of hyperhomocysteinemia. J. Biol. Chem. 278 (2003) 21504-31511
33. Schroecksnadel K., Winkler C., Wirleitner B., Schennach H., Weiss G., and Fuchs D. Anti-inflammatory compound resveratrol suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells in vitro. Clin. Chem. Lab. Med. 43 (2005) 1084-1088
34. Selhub J. Homocysteine metabolism. Annu. Rev. Nutr. 19 (1999) 217-246
35. Shay N.F., and Banz W.J. Regulation of gene transcription by botanicals: novel regulatory mechanisms. Annu. Rev. Nutr. 25 (2005) 297-315
36. Stead L.M., Brosnan M.E., and Brosnan J.T. Characterization of homocysteine metabolism in the rat liver. Biochem. J. 350 (2000) 685-692
37. Villanueva J.A., and Halsted C.H. Hepatic transmethylation reactions in micropigs with alcoholic liver disease. Hepatology 39 (2004) 1303-1310
38. Watanabe M., Osada J., Aratani Y., Kluckman K., Reddick R., Malinow M.R., and Maeda N. Mice deficient in cysthionine b-synthase: Animal models for mild and severe homocyst(e)inemia. Proc. Natl. Acad. Sci. USA 92 (1995) 1585-1589
39. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N. Engl. J. Med. 338 (1998) 1042-1050
40. Yilmaz O., Keser S., Tuzcu M., and Çetintaş B. Resveratrol (trans-3,4′,5-trihydroxystilbene) decreases lipid peroxidation level and protects antioxidant capacity in sera and erythrocytes of old female Wistar rats induced by the kidney carcinogen potassium bromate. Environ. Toxicol. Pharmacol. 24 (2007) 79-85